Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesShould Patients with High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy
The Oncologist, 10/28/09
Schuetze SM et al. – In multiple analyses, patients with high–risk soft tissue sarcoma treated with chemotherapy have a >10% absolute lower risk for disease recurrence and longer disease–specific survival than patients treated without chemotherapy. In the absence of conclusive results from an adequately powered, randomized, controlled clinical trial, the available data support the use of chemotherapy in the management of high–risk, localized, soft tissue sarcoma.
Related Articles
Pathology of Soft Tissue Sarcomas
Clinical Oncology, 10/07/09
Relevance Score: 83%
Harmonizing adult and pediatric approaches to the treatment of soft-tissue sarcoma
Expert Review of Anticancer Therapy, 11/12/09
Relevance Score: 82%
Expression of M-CSF and CSF-1R Is Correlated with Histological Grade in Soft Tissue Tumors
Anticancer Research, 11/10/09
Relevance Score: 82%
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
European Journal of Cancer, 10/29/09
Relevance Score: 82%
Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09
Relevance Score: 82%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
British Journal of Cancer, 12/11/09
Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 12/10/09
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation
European Journal of Cancer, 12/10/09
Today in Soft Tissue/Sarcoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype
British Journal of Cancer, 12/10/09
Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution
Anti-Cancer Drugs, 12/10/09
Angiosarcoma of the Breast: A Rare Clinicopathological Entity
American Journal of Clinical Oncology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor